Skip to main content

Table 1 Baseline demographic data of septic patients treated or not treated with intravenous ascorbic acid

From: Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis

Treatment Gender Age APACHE II scorea SOFA scoreb
Placebo 4 male 4 female 54 – 68 years 20.4 (15 – 29) 13.3 ± 2.9
Lo-AscA 5 male 3 female 30 – 70 years 20.4 (12 – 23) 10.1 ± 2.0
Hi-AscA 4 male 4 female 49 – 92 years 24.0 (12 – 33) 10.8 ± 4.4
  1. a APACHE Acute Physiology and Chronic Health Evaluation, mean (range).
  2. b SOFA Sequential Organ Failure Assessment, mean ± SE.